BMY: Message Board for Bristol-Myers Squibb Co. - InvestorVillage

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous 2500 Messages Top of Message List
Go to Msg #  
MSG # SUBJECT TYPE AUTHOR SENTIMENT RECS DATE POSTED
6385 NEJM 5Mar2021 Article " Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma" (Checkmate-9ER) GN JBWIN 1 3/3/2021 6:40:46 PM
6384 Bristol-Myers Squibb Co. (BMY) Management Presents at Cowen Virtual 41st Annual Health Care Conference Call GN teflon2000 1 3/3/2021 6:14:26 PM
6383 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat - perhaps you will find CMO Samit Hirawat's coverage of CELMoDs at Cowen more to your liking, Doolen! GN Doolen 3 3/3/2021 5:39:32 PM
6382 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat - perhaps you will find CMO Samit Hirawat's coverage of CELMoDs at Cowen more to your liking, Doolen! GN JBWIN 4 3/3/2021 5:26:10 PM
6381 Looking forward to presentation of both Deucra (Oral TYK-2) Psoriasis Phase IIIs at American Academy of Dermatology Virtual AAD VMX 23-25Apr2021 GN JBWIN 4 3/3/2021 5:08:14 PM
6380 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat - perhaps you will find CMO Samit Hirawat's coverage of CELMoDs at Cowen more to your liking, Doolen! GN JBWIN 4 3/3/2021 4:59:05 PM
6379 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat GN Biotech2050 0 3/3/2021 3:38:24 PM
6378 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat GN Doolen 3 3/3/2021 3:25:34 PM
6377 Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat GN Biotech2050 0 3/3/2021 3:12:44 PM
6376 Re: BINGO: At minute 23:55 of this myeloma video "Could CELMoDs possibly replace iMiDs?" GN Biotech2050 2 3/3/2021 3:04:59 PM
Previous 2500 Messages Top of Message List
Go to Msg #  








Financial Market Data provided by
.
Loading...